BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7380189)

  • 1. Prostaglandins and renal function in patients with ascites.
    Bartoli E; Chiandussi L
    Gastroenterology; 1980 May; 78(5 Pt 1):1120-1. PubMed ID: 7380189
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prostaglandin A 1 on renal and adrenal function in man.
    Fichman MP; Littenburg G; Brooker G; Horton R
    Circ Res; 1972 Sep; 31(9):Suppl 2:19-35. PubMed ID: 4341478
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1994; 18(6-7):568-73. PubMed ID: 7875416
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins and the regulation of renal circulation and function.
    Gerber JG; Anderson RJ; Schrier RW; Nies AS
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():227-54. PubMed ID: 6216784
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver disease and the renal prostaglandin system.
    Stokes JB
    Gastroenterology; 1979 Aug; 77(2):391-3. PubMed ID: 447050
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of eicosanoids in the control of renal function in severe hepatic disease.
    Dunn MJ
    Gastroenterology; 1984 Dec; 87(6):1392-5. PubMed ID: 6436137
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors responsible for renal sodium retention in hepatic cirrhosis with ascites].
    Arroyo V; Rodes J; Gutiérrez-Lizárraga MA; Revert L
    Rev Clin Esp; 1975 Nov; 139(3):261-7. PubMed ID: 1197850
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin causes renal vasodilatation independently of renal prostaglandins in healthy humans.
    Stenvinkel P; Alvestrand A
    Nephrol Dial Transplant; 1994; 9(12):1728-33. PubMed ID: 7708255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function in cirrhosis and the effects of prostaglandin A.
    Arieff AI; Chidsey CA
    Am J Med; 1974 May; 56(5):695-703. PubMed ID: 4596651
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F; Bomzon A; Allard J; Liu P; Blendis L
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal prostaglandins and the control of renal function in liver disease.
    Epstein M
    Am J Med; 1986 Jan; 80(1A):46-55. PubMed ID: 3511684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
    Guevara M; Fernández-Esparrach G; Alessandria C; Torre A; Terra C; Montañà X; Piera C; Alvarez ML; Jiménez W; Ginès P; Arroyo V
    Hepatology; 2004 Sep; 40(3):646-51. PubMed ID: 15349903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal retention of sodium in cirrhosis and fulminant hepatic failure.
    Wilkinson SP; Moodie H; Alam A; Williams R
    Postgrad Med J; 1975 Aug; 51(598):527-31. PubMed ID: 1234336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.